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Abstract. 
 
Major histocompatibility complex (MHC) 
class II molecules are transported to intracellular MHC 
class II compartments via a transient association with 
the invariant chain (Ii). After removal of the invariant 
chain, peptides can be loaded onto class II molecules, a 
process catalyzed by human leukocyte antigen-DM 
(HLA-DM) molecules. Here we show that MHC class 
II compartments consist of two physically and function-
ally distinct organelles. Newly synthesized MHC class 
II/Ii complexes were targeted to endocytic organelles 
lacking HLA-DM molecules, where Ii degradation oc-
curred. From these organelles, class II molecules were 
transported to a distinct organelle containing HLA-
DM, in which peptides were loaded onto class II mole-
cules. This latter organelle was not directly accessible 
via fluid phase endocytosis, suggesting that it is not part 
of the endosomal pathway. Uptake via antigen-specific 
membrane immunoglobulin resulted however in small 
amounts of antigen in the HLA-DM positive or-
ganelles. From this peptide-loading compartment, class 
II–peptide complexes were transported to the plasma 
membrane, in part after transit through endocytic or-
ganelles. The existence of two separate compartments, 
one involved in Ii removal and the other functioning in 
HLA-DM–dependent peptide loading of class II mole-
cules, may contribute to the efficiency of antigen pre-
sentation by the selective recruitment of peptide-recep-
tive MHC class II molecules and HLA-DM to the same 
subcellular location.
M
 
ajor 
 
histocompatibility complex (MHC)
 
1
 
 class II
molecules present peptides on the cell surface of
antigen presenting cells to T helper cells (Ger-
main, 1994). Such peptides are usually derived from anti-
gens internalized into the endocytic/lysosomal pathway
while newly synthesized class II molecules are targeted to
endocytic compartments via their association with the in-
variant chain (Ii) (Cresswell, 1994
 
a
 
; Pieters, 1997
 
a
 
).
Association of class II molecules with Ii occurs directly
after translation in the endoplasmic reticulum (Kvist et al.,
1982), and serves at least three functions (Wolf and
Ploegh, 1995; Pieters, 1997a). First, Ii guides the folding
and egress of the class II complex from the endoplasmic
reticulum (Anderson and Miller, 1992). Second, Ii associa-
tion with class II molecules prevents them from binding
antigenic peptides at early stages during biosynthesis
(Teyton et al., 1990; Roche and Cresswell, 1991). Third, Ii
provides targeting signals for transport of class II mole-
cules to the endosomal/lysosomal pathway (Bakke and
Dobberstein, 1990; Lotteau et al., 1990; Pieters et al.,
1993).
The targeting of newly synthesized class II/Ii complexes
to the endocytic/lysosomal pathway occurs via dileucine
based signals that reside within the Ii cytoplasmic tail (Bakke
and Dobberstein, 1990; Lotteau et al., 1990; Pieters et al.,
1993). Upon arrival in endosomal organelles, the class II–
associated Ii is stepwise degraded. Degradation of Ii oc-
curs from the COOH-terminal, lumenal side and results in
the formation of NH
 
2
 
-terminal, cytoplasmic Ii fragments
that remain associated to class II molecules (Blum and
Cresswell, 1988; Pieters et al., 1991). Besides containing
the endosomal targeting sequences, the class II–associated
Ii fragments also retain the class II–associated invariant
chain peptide (CLIP). CLIP associates with class II mole-
cules in a manner quite similar to antigenic peptides
(Ghosh et al., 1995), and therefore CLIP or CLIP-contain-
ing fragments need to be removed before antigenic pep-
tide loading (Roche, 1996; Pieters, 1997
 
a
 
).
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Removal of Ii fragments from the class II complex is me-
diated by human leukocyte antigen-DM (HLA-DM) mole-
cules, class II like molecules that consist of an 
 
ab
 
 het-
erodimer (Cho et al., 1991; Kelly et al., 1991; Denzin and
Cresswell, 1995; Stebbins et al., 1996). Mutant cell lines
lacking these molecules are defective in presenting pep-
tides derived from intact antigens (Mellins et al., 1990) and
class II molecules expressed by such mutants are predomi-
nantly loaded with CLIP (Riberdy et al., 1992). This im-
plied that DM may facilitate the exchange of Ii fragments
for antigenic peptides (Cresswell, 1994
 
b
 
; Roche, 1995) and,
indeed, several groups have confirmed a peptide-exchange
function for HLA-DM (Denzin and Cresswell, 1995; Sher-
man et al., 1995; Sloan et al., 1995). More recent work re-
vealed that HLA-DM can also edit peptide loading of
class II in the absence of Ii fragments (Katz et al., 1996;
Kropshofer et al., 1996; Roche, 1996; van Ham et al., 1996;
Weber et al., 1996). HLA-DM is located in class II positive
organelles, to which it is targeted via a tyrosine-based sig-
nal that is present in the cytoplasmic tail of the HLA-DM
 
b
 
 chain (Karlsson et al., 1994; Sanderson et al., 1994;
Marks et al., 1995; Copier et al., 1996; Pierre et al., 1996).
How the processes involved in the generation of class
II–peptide complexes, i.e., invariant chain degradation
and HLA-DM–dependent peptide loading are controlled
in time and in space within an antigen-presenting cell is
not known. Recent work from several laboratories has re-
vealed the existence of specialized organelles, MHC class
II compartments, in a variety of antigen-presenting cells
(Peters et al., 1991; Pieters et al., 1991; Amigorena et al.,
1994; Qiu et al., 1994; Tulp et al., 1994; West et al., 1994).
Within these class II compartments, the class II–associated
invariant chain is degraded and peptides are loaded onto
class II molecules. From these organelles, peptide-loaded
class II dimers are transported to the cell surface (Ami-
gorena et al., 1994; Tulp et al., 1994; West et al., 1994).
MHC class II compartments, as revealed by immunocy-
tochemistry, appear as multivesicular or multilaminar or-
ganelles (Peters et al., 1991, 1995; Pieters et al., 1991). In
addition to being morphologically heterogeneous, these
compartments differ in their content of Ii as well as en-
docytic markers (Pieters et al., 1991; Peters et al., 1995).
As defined by the degradation of Ii and class II peptide
loading, class II compartments can biochemically be dis-
tinguished from early and late endosomes as well as from
lysosomes in several cell types (Amigorena et al., 1994; Tulp
et al., 1994; West et al., 1994; Pieters, 1997
 
b
 
). In some
cases, however, class II–containing organelles were found
to colocalize predominantly with lysosomal compartments
(Qiu et al., 1994) or with both endosomes and lysosomes
(Castellino and Germain, 1995). Together, the morpholog-
ical and biochemical evidence suggest that class II mole-
cules may be distributed among various compartments
linked to the endosomal/lysosomal pathway. Whether or
not distinct functions in class II peptide loading can be as-
signed to different organelles is not known.
Here, we demonstrate that the MHC class II compart-
ments, as originally defined to function in Ii degradation
and antigenic peptide loading, consist of two physically and
functionally distinct organelles. MHC class II–Ii complexes
were first transported to an endocytic compartment where
the associated Ii was degraded. From there, class II com-
 
plexes were transported to a distinct, Ii negative organelle
population that contained HLA-DM. The latter compart-
ment was not part of the endocytic pathway, and func-
tioned in antigenic peptide loading. In contrast to fluid
phase endocytosed protein, antigen internalized via spe-
cific immunoglobulin receptor molecules did reach this
peptide loading compartment. The existence of a compart-
ment involved in peptide loading, that is distinct from the
one where Ii is degraded and not accessible to the bulk of
endocytosed material, may contribute to the efficiency of
antigen presentation to CD4
 
1
 
 T cells.
 
Materials and Methods
 
Cell Lines and Antibodies
 
The human melanoma cell line Mel JuSo (Johnson et al., 1981) was grown
in RPMI-1640 supplemented with 5% fetal calf of serum (RPMI-FCS) as
described (Pieters et al., 1991). Mel JuSo cells that were transfected with
the heavy and light chain of immunoglobulin specific for tetanus toxin
have been described (Knight et al., 1997). Tetanus toxin C fragment was
labeled using iodobeads (Pierce Chem. Co., Rockford, IL) with Na
 
125
 
I to a
specific activity of 
 
z
 
2.7 
 
3
 
 10
 
6
 
 cpm/
 
m
 
g (Markwell, 1982). The following an-
tibodies were used: anti-Ii rabbit antiserum MDDQ, raised against the
NH
 
2
 
-terminal fragment of Ii; VIC-Y1 (anti-IiN mAb), a kind gift from Dr.
W. Knapp (University of Vienna, Vienna, Austria); mAb L243, a kind gift
from Dr. T. Johnson (University of Munich, Munich, Germany); mAb
Tu36 (PharMingen, San Diego, CA); anti-MHC class II rabbit antiserum,
a kind gift of Dr. H.L. Ploegh (Harvard University, Cambridge, MA);
anti–HLA-DM antiserum, a kind gift of Dr. E. Mellins (Stanford Univer-
sity, Stanford, CA); mAb 5C1 (anti–HLA-DM) (Sanderson et al., 1996), a
kind gift of Dr. J. Trowsdale (University of Cambridge, Cambridge,UK);
and DM.K8/2b, a kind gift of Dr. G. Hammerling (German Cancer Re-
search Center, Heidelberg, Germany). Texas-red and FITC-coupled goat
anti–rabbit and goat anti–mouse antibodies were purchased from South-
ern Biotechnology Associates (Birmingham, AL) or Zymed Laboratories
Inc. (Seattle, WA).
 
Subcellular Fractionation
 
Monolayers of Mel JuSo cells were grown to subconfluency in tissue cul-
ture dishes. After scraping the cells in homogenization buffer (10 mM tri-
ethanolamine, 10 mM acetic acid, 1 mM EDTA, 0.25 M sucrose, pH 7.4), a
membrane fraction was prepared as described (Tulp et al., 1994). The ho-
mogenate was adjusted to 1.5 mg protein/500 
 
m
 
l in homogenization buffer
and layered on top of a 0.8–1.2 M sucrose gradient prepared in homogeni-
zation buffer using the Gradient Master (Nycomed Pharma, Oslo, Nor-
way) in a Beckman SW 28 tube. After centrifugation (12 h at 27,000 rpm
in a Beckman SW28 rotor at 4
 
8
 
C), 0.4–1-ml fractions were collected from
the top. The variation of the fraction volume size in the different experi-
ments is reflected by different fraction numbers shown in the Figures. Or-
ganelle electrophoresis was carried out essentially as described (Tulp et
al., 1994; Engering et al., 1997). In brief, membranes in the different frac-
tions after sucrose density centrifugation were collected and sedimented
after dilution to 0.25 M sucrose by centrifugation in a SW28 rotor (Beck-
man) at 27,000 rpm for 1 h at 4
 
8
 
C. The membranes were resuspended in
homogenization buffer containing 6% Ficoll-70 (Pharmacia) and electro-
phoresed for 55 min at 10.4 mA. 0.5-ml fractions were collected and
assayed for the different markers (see below). For concentration of mem-
branes, pooled fractions were sedimented in an Optima TLX Ultracentri-
fuge (Beckman Instrs., Carlsbad, CA) (45 min at 55,000 rpm in a TLA 120
rotor at 4
 
8
 
C). 
 
Analysis of Organelle Markers
 
For endosome labeling, cells were incubated with horse radish peroxidase
(Sigma type VIa) at 2 mg/ml in internalization medium (DMEM supple-
mented with 10 mM glucose and 10 mM Hepes pH 7.4 [Gruenberg et al.,
1989]). After 5 min at 37
 
8
 
C, cells were cooled on ice, washed three times
with ice cold Dulbecco’s PBS containing 10% BSA, once with prewarmed
RPMI-FCS, and then incubated for the times indicated at 37
 
8
 
C in the
same medium. The activity of the enzyme 
 
b
 
-hexosaminidase was assayed
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as described (Koldovsky and Palmieri, 1971). Total protein was deter-
mined according to Bradford (Bradford, 1976), using bovine gamma glob-
ulin (Bio-Rad Labs., Hercules, CA) as a standard.
 
Metabolic Labeling and Pulse Chase
 
Before labeling, the cells were grown for 30 min in methionine/cysteine-
free medium containing 5% dialyzed FCS. Labeling was performed by
placing the cells in methionine/cysteine-free medium containing 5% dia-
lyzed FCS and 0.15–0.3 mCi/ml [
 
35
 
S]methionine/cysteine mix (Promix;
Amersham Corp., Arlington Heights, IL) for 20 min. After the pulse, cells
were washed twice in RPMI-FCS containing 5 mM cold methionine and
5 mM cold cysteine. Chase was performed at 37
 
8
 
C in RPMI-FCS supple-
mented with 5 mM of methionine and cysteine each.
 
Immunoprecipitation and Immunoblotting
 
For immunoprecipitation, subcellular fractions were adjusted to 10 mM
Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM MgCl
 
2
 
, and 1% Triton X-100 and a
mixture of protease inhibitors (chymostatin [10 
 
m
 
g/ml], leupeptin [10 
 
m
 
g/ml],
aprotinin [10 
 
m
 
g/ml], antipain [10 
 
m
 
g/ml], pepstatin [10 
 
m
 
g/ml], and PMSF
[1 mM]) was added to the supernatant. After incubation with the antibod-
ies indicated, the samples were centrifuged at 20,000 
 
g
 
 for 15 min, after
which 50 
 
m
 
l of a protein A–Sepharose (1:1; Pharmacia) slurry was added.
After a further 2-h incubation at 4
 
8
 
C, the protein A beads were washed
and eluted as described (Pieters et al., 1991). SDS-PAGE was performed
according to Laemmli (Laemmli, 1970). For detection of SDS-stable class
II complexes, immunoprecipitated material was eluted from the protein
A–Sepharose beads at room temperature for 20 min before SDS-PAGE
and fluorography. For quantitation, the radioactivity associated with pro-
teins fixed in the dried gels was determined by Phosphor Image analysis
(Molecular Dynamics, Sunnyvale, CA). Alternatively, autoradiographs were
scanned using a Molecular Dynamics scanner, and relative intensities
were determined using the software supplied. For detection of polypep-
tides following immunoblotting, membrane fractions were either sedi-
mented in an Optima TLX Ultracentrifuge (Beckman) (45 min at 55,000
rpm in a TLA 120.1 rotor at 4
 
8
 
C) or proteins were concentrated by precip-
itation in 10% trichloric acetic acid on ice, followed by centrifugation at
20,000 g for 30 min. Membrane or protein pellets were resuspended in
Laemmli sample buffer, proteins were separated by SDS-PAGE and
transferred to nitrocellulose using a Trans-Blot device (Bio-Rad Labs.).
Alternatively, 20–100-
 
m
 
l aliquots from the fractions were applied directly
to nitrocellulose. After incubation of the membrane in 5% lowfat milk in
PBS containing 0.2% Tween-20, the nitrocellulose was incubated with
specific antibodies, washed and incubated with peroxidase-coupled sec-
ondary antibodies and developed by chemoluminescence (ECL; Amer-
sham). For quantitation, resulting films were scanned after which the rela-
tive intensity was determined using the NIH Image Software.
 
Immunofluorescence Microscopy
 
Cells were grown on glass coverslips and fixed in 3% paraformaldehyde
followed by permeabilization in 0.1% Triton X-100 or fixed in methanol
as described (Pieters et al., 1993). Coverslips were incubated with primary
antibodies for 40 min at room temperature, washed in PBS containing 5%
fetal calf serum and then incubated with FITC and Texas red coupled goat
anti-rabbit and goat anti-mouse antibodies. Coverslips were mounted in
Mowiol (Hoechst) containing 100 mg/ml DABCO (Sigma) or in Fluoro-
Guard Antifade Mounting Reagent (Bio-Rad Labs.), and analyzed using
a confocal laser scanning microscope system (MRC-1024, equipped with
522/32-nm and 605/32-nm band pass filter for FITC and Texas red, respec-
tively; Bio-Rad Labs.) attached to an Axiovert 100 microscope (Carl Zeiss,
Inc., Thornwood, NY). Images were collected using the 488 nm (FITC)
and 568 nm (Texas red) lines of an argon krypton laser, with pinhole set-
tings at 2.0 and 2.5 for FITC and Texas red, respectively.
 
Results
 
Isolation of Distinct MHC Class II
Containing Organelles
 
The human HLA-DR3 positive cell line Mel JuSo is a use-
ful model cell line for studying the cell biology of antigen
processing and presentation in that it efficiently processes
and presents antigens to CD4
 
1
 
 T cells (Chen and Hersey,
1991; Tulp et al., 1994; Knight et al., 1997). Besides expres-
sing HLA-DR, it is positive for the class II–associated Ii as
well as for HLA-DM molecules (Pieters et al., 1991; Sand-
erson et al., 1994; Tulp et al., 1994) and contains large num-
bers of MHC class II positive organelles (Pieters et al.,
1991; Tulp et al., 1994). When such organelles are isolated
from other subcellular organelles on the basis of their charge
characteristics, they can be distinguished from early and
late endosomes but comigrate in such separation proce-
dures with lysosomes (Tulp et al., 1994). To separate class
II positive organelles from lysosomes, conditions were es-
tablished using isopycnic centrifugation in sucrose (De Duve,
1965) that enriched class II–containing organelles while
depleting lysosomes. Mel JuSo cells were allowed to inter-
nalize the fluid phase endocytic tracer horse radish peroxi-
dase (HRP) for 5 min, followed by a 15-min chase to allow
transport to class II–containing organelles (Tulp et al.,
1994). Membranes were prepared as described in Materi-
als and Methods, and separated using various gradients
ranging from 0.6–1.6 M sucrose (not shown). We found
that a 0.8–1.2 M sucrose gradient resulted in a recovery of
HRP in membranes migrating in the top fractions of the
gradient while lysosomes, identified by the presence of
 
b
 
-hexosaminidase, sedimented at the bottom of the gradi-
ent (Fig. 1 
 
a, top 
 
and
 
 middle
 
). Small amounts of 
 
b
 
-hex-
osaminidase activity were also present in the light (frac-
tion 1–25) and intermediate (25–60) density fractions (Fig.
1
 
 a, top
 
). The bulk of subcellular organelles, including the
endoplasmic reticulum and Golgi compartments migrated
in the top fractions of the gradient, as judged by the analy-
sis of the total amount of protein in the different fractions
(Fig. 1 
 
a, bottom
 
). Thus, the here established 0.8–1.2 M su-
crose gradient resulted in the depletion of lysosomes from
most other subcellular organelles.
To analyze the distribution of MHC class II–containing
organelles across the 0.8—1.2 M sucrose gradient, an ali-
quot of the different fractions was subjected to slot blot
analysis followed by immunostaining with the anti–MHC
class II mAb L243. As shown in Fig. 1 
 
b, top
 
, two major
populations of MHC class II molecules migrated in the top
and the middle part of the gradient, respectively. A minor
population of MHC class II molecules comigrated with the
lysosomal marker 
 
b
 
-hexosaminidase. The distribution of
the Ii, was similarly analyzed using an antibody raised
against the NH
 
2
 
-terminal cytoplasmic tail of Ii. Ii contain-
ing organelles were almost exclusively present in the light
part of the gradient (Fig. 1 
 
b, middle
 
). HLA-DM mole-
cules were distributed in the light as well as in the interme-
diate density fractions, with only small amounts present
in the dense fractions (Fig. 1 
 
b, bottom
 
), in agreement with
its distribution in B cells (Kropshofer et al., 1997). The
slightly different distribution of class II and HLA-DM
molecules most probably resulted from plasma membrane
fragments containing large amounts of class II molecules.
Indeed, the plasma membrane was recovered from the
light, intermediate and dense parts of the gradient, as ana-
lyzed by the presence of metabolically labeled and chased
MHC class I molecules (data not shown).
Thus, following isopycnic centrifugation in sucrose, two
class II–containing organelle populations displaying differ-
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ent buoyant density could be distinguished; only within the
lighter of these two populations the class II–associated in-
variant was detected, while both populations contained
HLA-DM.
 
Localization of Invariant Chain and HLA-DM in Two 
Distinct MHC Class II Positive Organelles
 
As noted above, while sucrose density gradient centrifuga-
tion results in separation of organelles having a different
buoyant density, several types of membranes comigrate dur-
ing such a procedure. To achieve a better separation of sub-
cellular organelles, density centrifugation was combined with
organelle electrophoresis. During such electrophoresis, or-
ganelles can be separated that display differences in their
charge characteristics (Marsh et al., 1987; Tulp et al., 1993;
Engering et al., 1997).
To purify MHC class II–containing organelles from the
two class II positive pools resulting after isopycnic centrif-
ugation in sucrose, a two-step fractionation procedure was
established. Cells were allowed to internalize HRP for 5 min
followed by a 15-min chase after which a homogenate was
prepared. In a first step, organelles were separated by
isopycnic centrifugation in sucrose to deplete lysosomal
organelles from other subcellular organelles. Fractions 1-12
(
 
Pool I
 
) and fractions 13-28 (
 
Pool II
 
) as indicated in Fig. 2
 
a
 
, were pooled separately. Membranes from each pool
were sedimented at 100,000 
 
g
 
, resuspended, and then sub-
jected to organelle electrophoresis as described in Materi-
als and Methods; acidic organelles, including endosomes
and lysosomes shift towards the anode during such separa-
tion (Harms et al., 1980; Engering et al., 1997), and are re-
covered in the first fractions (Fig. 2, 
 
b
 
 and 
 
c
 
, 
 
shifted
 
). Most
other subcellular organelles do not migrate in the electric
field and are recovered at the cathodic side. The resulting
fractions were analyzed for the presence of HRP and
 
b
 
-hexosaminidase activity as well as for the amount of to-
tal protein to analyze the migration of other subcellular
organelles. As shown in Fig. 2 
 
b
 
 and 
 
c
 
, each pool could be
separated in a anodally “shifted” fraction and a fraction
containing the bulk of the protein, including ER/Golgi as
well as plasma membrane components (unshifted fractions)
(Tulp et al., 1994). The anodally shifted membranes from
pool I contained little 
 
b
 
-hexosaminidase activity but con-
tained the endocytic marker HRP (Fig. 2 
 
b
 
). In contrast,
anodally shifted membranes from pool II contained no
measurable HRP activity, but were positive for 
 
b
 
-hex-
osaminidase (Fig. 2 
 
c
 
).
To analyze the distribution of MHC class II and HLA-
DM, membranes in the different fractions were pooled as
indicated in Fig. 2, 
 
d–g
 
 and sedimented at 100,000 
 
g
 
. After
SDS-PAGE and transfer to nitrocellulose, the presence of
MHC class II molecules and HLA-DM was detected by im-
munostaining. As expected, anodally shifted membranes
from both pool I and pool II contained MHC class II mol-
ecules (Fig. 2, 
 
d
 
 and 
 
e
 
). In contrast, only the anodally shifted
Figure 1. (a) Sedimentation profiles of endosomal and lysosomal organelles after isopycnic centrifugation is sucrose. Mel JuSo cells
were allowed to internalize HRP for 5 min followed by a 15-min chase. Cells were homogenized and a post-nuclear supernatant was
loaded on a sucrose gradient (0.8–1.2 M sucrose in homogenization buffer). After centrifugation and fractionation of the gradients (left
top, right bottom), each fraction was analyzed for the activity of b-hexosaminidase (b-hex, top) and HRP (middle). (Bottom) Total pro-
tein content in the different fractions as analyzed by Bradford. Shown are mean (6 SD) from three separate experiments. (b) Steady
state distribution of MHC class II, Ii and HLA-DM molecules in subcellular organelles. Proteins from each fraction after sucrose density
gradient centrifugation (left top, right bottom) were allowed to bind to nitrocellulose after which the amount of MHC class II (top), Ii
(middle) or HLA-DM (bottom) was analyzed by immunostaining, using specific antibodies. Shown are mean (6 SD) obtained from
three separate gradients.
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Figure 2. Isolation of distinct MHC class II–containing organelles. (a) Mel JuSo cells were allowed to internalize HRP for 5 min, follow-
ing by a 15-min chase. Cells were homogenized and a postnuclear supernatant was applied to a 0.8–1.2 M sucrose gradient (left top, right
bottom). After centrifugation, fractions were analyzed for HRP activity (open bars) and b-hexosaminidase (filled bars). Fractions 1-12
(Pool I) and 13-28 (Pool II) were sedimented at 100,000 g and each pool was applied to organelle electrophoresis. (b and c) Distribution
of HRP (b, filled triangles) and b-hexosaminidase activity (c, filled circles) and total amount of protein (b, and c, open diamonds) after
electrophoresis of pool I and pool II, respectively. Anode, left, cathode, right. Fractions after electrophoresis were sedimented at 100,000 g
and proteins were subjected to 12% SDS-PAGE and transferred to nitrocellulose. The presence of MHC class II molecules (d and e) as
well as HLA-DM (f and g) was detected by immunostaining of the membrane.
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membranes from pool II contained HLA-DM, whereas af-
ter electrophoresis of pool I, HLA-DM was exclusively de-
tected in unshifted fractions containing ER/Golgi com-
partments (Fig. 2, f and g).
MHC class II–associated invariant chain degradation frag-
ments are being generated in Mel JuSo cells 2–4 h after
biosynthesis (Pieters et al., 1991; Tulp et al., 1994). To re-
veal the presence of class II–associated Ii degradation
products in the two class II positive organelle populations,
the above described two-step fractionation procedure was
applied to membranes prepared from cells that were meta-
bolically labeled for 20 min followed by a 3-h chase. From
both the shifted and unshifted membranes obtained after
electrophoresis of pool I and pool II, class II molecules
were immunoprecipitated and analyzed by SDS-PAGE.
As shown in Fig. 3, class II molecules in the shifted mem-
branes from the light pool (pool I) were assembled with Ii
degradation fragments IiP22, IiP18, and IiP12 (Fig. 3, lane
1). Interestingly, small amounts of IiP12 were present in
the shifted fractions from the denser pool (pool II; Fig. 3,
lane 3). IiP12 most probably includes the so-called CLIP
fragment (Pieters et al., 1991, Amigorena et al., 1995), and
like CLIP, this fragment can be removed from MHC class
II molecules by HLA-DM in exchange for peptides (Den-
zin and Cresswell, 1995; Stebbins et al., 1996).
Taken together, these data show that two physically dis-
tinct MHC class II containing organelle populations can
be defined based on density centrifugation; in the lighter
organelles, the Ii associated with MHC class II molecules
is being degraded, whereas the denser vesicle population
contains HLA-DM.
Localization of Ii and HLA-DM by 
Immunofluorescence Microscopy
The finding that Ii degradation products and HLA-DM re-
side in two distinct class II–containing organelles led us to
analyze the steady state distribution of Ii and HLA-DM by
confocal immunofluorescence microscopy. Cells were grown
on coverslips, fixed and permeabilized, and then stained
for Ii using anti-Ii NH2-terminal antibodies as well as for
HLA-DM molecules. Ii was localized in the Golgi area as
well as in a punctated pattern throughout the cytoplasm
(Fig. 4 a, a and d). HLA-DM was distributed in a punctated
staining pattern, as analyzed using both a purified poly-
clonal antiserum (Fig. 4 a, b) and an mAb (Fig. 4 a, e).
Some colocalization is apparent in the Golgi area, but
most HLA-DM positive structures did not label for Ii, as is
shown in Fig. 4 a, c and f, which depicts merging of the two
images. Both Ii and HLA-DM colocalized to a large de-
gree with MHC class II molecules, as expected (Fig. 4 b),
although the class II staining did not completely overlap
with Ii (Fig. 4 b, c) or HLA-DM (Fig. 4 b, f). These results
further corroborate the existence of two distinct MHC
class II organelle populations; one containing Ii immu-
noreactivity, the other positive for HLA-DM.
Transport of MHC Class II Complexes through Distinct 
Class II Positive Organelles
To analyze the kinetics of transport of newly synthesized
class II molecules through the Ii positive and HLA-DM
positive organelle population, pulse-chase analysis was com-
bined with the two-step subcellular fractionation. Cells were
metabolically labeled with [35S]methionine/cysteine for 20
min and chased for the times indicated in Fig. 5. At each
time point, membranes were prepared and subjected to
isopycnic centrifugation in sucrose, followed by organelle
electrophoresis of the separate pools. After electrophore-
sis, the shifted and unshifted membranes were pooled, and
the presence of newly synthesized class II complexes ana-
lyzed by immunoprecipitation and SDS-PAGE. As shown
in Fig. 5, after 2 h of chase, small amounts of class II mole-
cules had accessed the lighter, Ii positive class II–contain-
ing organelles, whereas very little was present in the den-
ser, HLA-DM positive class II organelles. Most class II
molecules, however, comigrated with ER/Golgi markers
in the unshifted pools. With increasing chase times (Fig. 5,
T 5 3 hours and T 5 4 hours), class II molecules migrated
from the Ii positive class II vesicle population (Fig. 5, pool
I, shifted) to the HLA-DM positive class II organelles
(pool II, shifted). Surprisingly, during 5 and 7 h of chase,
class II molecules became equally distributed between
both class II–containing organelles. Finally, class II mole-
cules are expected to be transported to the plasma mem-
brane: indeed, 12 and 48 h after biosynthesis all class II
molecules had migrated out of both class II containing ves-
icle populations and comigrated with plasma membrane in
the unshifted pools (Fig. 5, T 5 12 hours and T 5 48 hours).
Quantitation of the resulting autoradiographs revealed
that 3 h after biosynthesis, z50% of total newly synthe-
sized MHC class II molecules comigrated with the Ii posi-
tive class II–containing organelles, while only z5% was
present in the HLA-DM positive organelles. After 4 h of
chase, z30% of total class II molecules was present in the
HLA-DM positive class II containing organelle popula-
tion whereas z5% remained in the Ii positive organelles.
After 5 and 7 h of chase, z15% of the class II molecules
were present in both the Ii and HLA-DM positive shifted
fractions; at later chase times (T 5 12 hours and T 5 48
hours), ,1% of class II molecules remained in the class II–
containing shifted vesicle populations.
In general, MHC class II molecules are not subject to
degradation and indeed no loss of class II signal was ob-
Figure 3. Detection of Ii
fragments in class II–contain-
ing organelles. Cells were
metabolically labeled for 20
min with [35S]-methionine/
cysteine followed by a 3-h
chase. Membranes were pre-
pared and fractionated by su-
crose density centrifugation
followed by electrophoresis
as described in Fig. 2. Af-
ter electrophoresis, shifted
(lanes 1 and 3) and unshifted
(lanes 2 and 4) membranes
from pool I (lanes 1 and 2)
and pool II (lanes 3 and 4)
were pooled and class II mol-
ecules immunoprecipitated
followed by SDS-PAGE
analysis and fluorography.
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served up to 72 h after biosynthesis (results not shown).
Therefore, the time course of class II transport through
subcellular compartments suggests a sequential transit of
newly synthesized class II complexes from the trans-Golgi
network through organelles where the associated Ii is de-
graded, to the vesicle population containing HLA-DM. From
these latter, HLA-DM positive organelles, class II com-
plexes were exported to the plasma membrane, possibly
via endocytic organelles (see below).
Peptide Loading in MHC Class
II–containing Organelles
The presence of HLA-DM in the denser of the MHC class
II positive vesicle population together with the arrival of
newly synthesized class II molecules in these organelles af-
ter Ii degradation suggests that peptide loading would
occur in these organelles preferentially. To address the
formation of class II–peptide complexes, a series of pulse-
chases combined with the two-step subcellular fraction-
ation was performed. After immunoprecipitation, MHC-
class II complexes were resolved by SDS-PAGE analysis
under mildly denaturing conditions. As peptide loading
renders class II dimers SDS resistant, peptide-loaded class
II molecules appear as ab dimers migrating at z56 kD un-
der these conditions (Germain and Hendrix, 1991; Tulp et
al., 1994). In Mel JuSo cells, SDS-stable class II complexes
start to be formed 2 h after biosynthesis (Tulp et al., 1994
Figure 4. Localization of Ii
and HLA-DM by immunoflu-
orescence microscopy. (a)
Cells grown on coverslips
were fixed, permeabilized
and labeled for Ii using anti-Ii
NH2-terminal monoclonal (a)
or polyclonal (d) antibodies,
and HLA-DM using poly-
clonal (b) or monoclonal anti-
bodies (e) followed by FITC
(b and d) or Texas red (a and
e) conjugated secondary anti-
bodies. The superposition of
the images is shown in c and f.
In b, cells were labeled for
MHC class II molecules using
monoclonal (b) or polyclonal
(e) antibodies and double la-
beled for Ii using polyclonal
anti-Ii NH2-terminal antibod-
ies (a) or HLA-DM using
mAbs (d), followed by Texas
red (b and e) or FITC (a and
d) conjugated secondary anti-
bodies. c and f show the
merged images. Bars: 20 mm.
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and data not shown). Cells were biosynthetically labeled
for 20 min with [35S]methionine/cysteine followed by chases
in the absence of radiolabeled amino acids for the times in-
dicated in Fig. 6. To evaluate the percentage of class II
complexes that had acquired SDS resistance in the two or-
ganelle populations, the fluorographs shown represent an
equivalent class II signal in pool I and II per time point. 2 h
after biosynthesis, which is the time class II molecules start
to be transported into MHC class II–containing compart-
ments (Amigorena et al., 1994; Tulp et al., 1994), low
amounts of SDS-stable ab dimers comigrated with the
HLA-DM positive organelles (Fig. 6, T 5 2 hours, Pool II;
z10% of SDS-stable dimers present), but not with the Ii
positive vesicle population (Fig. 6, T 5 2 hours Pool I;
note that the fluorograph representing pool II has been
exposed five times longer than the one representing pool
I). Interestingly, a portion of SDS-stable class II dimers
were present in nonshifted fractions as well, probably re-
flecting a rapid transport of peptide loaded class II mole-
cules to the plasma membrane. 4 h after biosynthesis, SDS-
stable ab dimers almost exclusively comigrated with the
HLA-DM containing organelles (Fig. 6, T 5 4 hours Pool
II; z20% SDS-stable dimers present), while little class II
molecules remained in the shifted fractions of pool I (Fig.
6, T 5 4 hours). At this time point, unshifted membranes
from both pools contained SDS-stable dimers, most proba-
bly reflecting peptide-loaded class II dimers that have
reached the plasma membrane. After 7 h of chase, SDS-sta-
ble ab dimers were present in shifted membranes from
both pool I and pool II, indicating that peptide-loaded
class II dimers had again gained access to Ii positive mem-
branes. At late times of chase (Fig. 6, T 5 12 hours) SDS-
stable class II dimers were predominantly found to comi-
grate with plasma membrane fractions.
In conclusion, the formation of peptide-loaded MHC
class II dimers in the HLA-DM positive vesicle population
defines this site as the peptide-loading compartment.
Accessibility of the MHC Class II Positive 
Compartments to Internalized Antigen
Epitopes presented by MHC class II molecules at the
plasma membrane to T cells are usually derived from anti-
gens that are internalized in the endocytic pathway of the
presenting cell. The finding that the fluid phase marker
HRP, internalized for 15 min, is not found in membranes
comigrating with the peptide-loading compartment after
density centrifugation (see Figs. 1 and 2), suggested that
these organelles are not accessible via the endocytic path-
way. To analyze whether HRP accessed the loading com-
partment at different times of chase, cells were pulsed for
5 min with HRP at 378C, and chased in the absence of
HRP from 1 min up to 4 h. After homogenization and den-
sity centrifugation of membranes, the HRP activity was
determined in the different fractions (Fig. 7 a). The bulk of
HRP activity at any chase time point was present in frac-
tions containing the organelle population where Ii was de-
graded, with little HRP reactivity appearing in pool II at
the 15-min to 1-h chase times. To directly analyze the pres-
ence of HRP in both class II positive organelles at these
time points, membranes present in pool I and II from the
density gradient were subjected to electrophoresis. As shown
Figure 5. Pulse-chase analysis of class II transport through dis-
tinct subcellular organelles. Cells were labeled for 20 min with
[35S-]methionine/cysteine, followed by a chase for the times indi-
cated in the absence of radiolabel. At each time point, cells were
homogenized and membranes fractionated by sucrose density
centrifugation followed by organelle electrophoresis as described
in Fig. 2. Shifted (lanes 1 and 3) and unshifted (lanes 2 and 4) mem-
branes were pooled, class II molecules immunoprecipitated and
analyzed by SDS-PAGE and fluorography.
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in Fig. 7 b, virtually all HRP reactivity was recovered in
shifted membranes from pool I, consistent with HRP be-
ing distributed in endosomal organelles at these time points
(Griffiths et al., 1988; Parton et al., 1989; Zachgo et al.,
1992). Only trace amounts were detected in shifted mem-
branes from pool II, although some HRP reactivity was re-
covered at the loading phase (corresponding to fraction
50) probably representing HRP aggregates (not shown).
While fluid phase endocytosis is important for nonspe-
cific uptake of antigens, e.g., in dendritic cells (Steinman and
Swanson, 1995; Lanzavecchia, 1996), antigen-specific B
cells internalize antigens via membrane bound immuno-
globulin receptors (Lanzavecchia, 1987). The possibility
was investigated whether receptor-mediated antigen uptake
allowed transport of antigen into the HLA-DM positive
peptide-loading compartment. When Mel JuSo cells are
transfected with mIgG specific for tetanus toxin, they can
present this antigen at 1,000-fold lower concentrations to
T cells as compared to nontransfected Mel JuSo cells (Knight
et al., 1997). To analyze whether antigen uptake via recep-
tor-mediated internalization accessed the HLA-DM posi-
tive class II compartment, mIgG transfected Mel JuSo
cells were allowed to internalize 125I-labeled tetanus toxin
C fragment for 5 min at 378C, after which the cells were
chased in the absence of antigen for the times indicated in
Fig. 8 a. At each time point, cells were homogenized,
Figure 6. Formation of SDS-stable ab dimers in class II–containing subcellular organelles. Cells were labeled for 20 min with [35S]me-
thionine/cysteine, followed by a chase for the times indicated in the absence of radiolabel. At each time point, cells were homogenized
and membranes fractionated by sucrose density centrifugation and organelle electrophoresis as described in Fig. 2. Fractions after or-
ganelle electrophoresis were pooled as indicated, and class II molecules immunoprecipitated followed by SDS-PAGE under mildly dena-
turing conditions and fluorography. The protein peak migrated at fraction 26 (Pool I) and fraction 30 (Pool II), respectively. Note that
the fluorographs represent equal amount of the class II signal in pool I and II (see text).
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membranes fractionated by density centrifugation in su-
crose, and the radioactivity recovered in each fraction was
determined. As shown in Fig. 8 a, after 5 min internaliza-
tion at 378C (0-min chase), most of the radiolabel was
present in pool I, comigrating with the Ii positive class II
compartment. A small amount of radioactivity was also
detected in pool II. With increasing chase times, the
amount of radiolabel recovered from pool I gradually de-
creased, while the counts recovered from pool II containing
the peptide-loading compartment remained approximately
the same. To establish whether the activity recovered in
pool II was associated with the plasma membrane or had
accessed the class II positive compartments, fractions ob-
tained after density gradient centrifugation were pooled
and subjected to organelle electrophoresis. As shown in
Fig. 8, b and c, after 1 h of chase, while most of the radiolabel
was in fact associated with unshifted membranes (presum-
ably plasma membrane and early endosomes [Tulp et al.,
1993]), z30% of the label was associated with shifted mem-
branes from pool I, whereas z20% was found in shifted
membranes from pool II. Together these data indicate that
after uptake via specific antigen receptors, small but signif-
icant amounts of antigen were transported to the peptide-
loading compartment, in contrast to material internalized
via fluid phase endocytosis.
Discussion
Two chaperones function at different stages in the MHC
class II peptide-loading pathway: the Ii and the HLA-DM
molecules. Whereas Ii serves to target class II molecules to
endocytic compartments, the HLA-DM dimer functions in
catalyzing peptide loading onto class II molecules that
these encounter intracellularly (Wolf and Ploegh, 1995;
Pieters, 1997a,b). In this paper, we characterized the sub-
cellular compartments where Ii is being degraded and
where HLA-DM–dependent peptide loading occurs. Sur-
prisingly, these two events were found to occur in two
physically distinct organelles; the class II–associated Ii was
degraded in a light, endosomal compartment, whereas
HLA-DM was located in a distinct compartment of inter-
mediate density in which peptides were loaded onto class
II molecules. This DM positive compartment could not be
accessed via fluid phase endocytosis; it was, however, ac-
cessible to antigen after receptor mediated internalization.
Thus, the recently characterized MHC class II compart-
ment that was shown to mediate both Ii degradation and
peptide loading, in fact consists of two distinct organelles,
each carrying out a specific function.
A class II positive nonlysosomal compartment with sim-
ilar characteristics to the organelles described here has
been isolated from human and murine B cells. In these or-
ganelles, Ii is being degraded and peptides loaded onto
class II complexes before their transport to the cell surface
(Amigorena et al., 1994, 1995; West et al., 1994). Interest-
ingly, in these B cells the class II compartments are only
partially accessible to endocytic tracers (Amigorena et al.,
1994), and, antigen internalized via mIgG receptors is rap-
idly transported to class II compartments (West et al.,
1994). This suggest that also in B cells the class II compart-
ment comprises an endocytic organelle population, as well
as a compartment that functions in peptide loading of class
II molecules.
A Separate Peptide-loading Compartment
Degradation of the class II associated Ii results in the for-
mation of various Ii NH2-terminal fragments associated
Figure 7. Kinetics of transport of HRP through intracellular compartments. Cells were allowed to internalize HRP for 5 min, followed
by a chase for the times indicated in the different panels. Membranes were prepared and fractionated by sucrose density centrifugation
(a) and organelle electrophoresis (b) for the times indicated.
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with class II (IiP22, IiP18, and IiP12 [Blum and Cresswell,
1988; Pieters et al., 1991]). IiP12, that most probably in-
cludes the CLIP sequence, remains associated with class II
molecules for prolonged times (.4 h) (Pieters et al., 1991;
Amigorena et al., 1995), and, class II associated with Ii
NH2-terminal fragments such as IiP12 can serve as a sub-
strate for HLA-DM, in a manner similar to class II-CLIP
complexes (Denzin and Cresswell, 1995; Stebbins et al.,
1996). Indeed, 3 h after synthesis, which is the time class
II–peptide complexes were beginning to be detected, ab-
IiP12 was found in the peptide loading compartment.
There, the presence of HLA-DM would result in removal
of IiP12 from class II in favor of antigenic peptides; it can,
however, not be excluded that CLIP is formed from IiP12
in the peptide loading compartment before DM assisted
antigenic peptide loading of class II molecules.
Newly synthesized class II molecules first accessed the
peptide loading compartment 2–3 h after biosynthesis.
Within 4 h after biosynthesis, most class II complexes were
transported to the peptide loading compartment, where
they acquired resistance to SDS, indicative of the acquisi-
tion of peptides. What causes transport of class II mole-
cules into the peptide-loading compartment remains to be
established. One possibility is that degradation of the lu-
menal part of Ii leads to differences in the oligomeric state
of class II complexed with Ii fragments. Indeed, recent
work suggests that the oligomeric state of Ii dictates its pre-
cise subcellular localization (Arneson and Miller, 1995). In
that case, IiP12 may target the associated class II to the
peptide loading compartment. Alternatively, degradation
of the Ii lumenal part may unmask a targeting signal in the
class II molecules themselves, possibly residing in the class
II b-chain (Chervonsky et al., 1994).
Whether or not the here described compartments origi-
nate from each other through the process of maturation or
whether cargo is transported between preexisting organelles
through budding and fusion of transport vesicles, remains
to be established (Griffiths and Gruenberg, 1991; Murphy,
1991; Mellman, 1996). Most subcellular organelles that are
part of the biosynthetic and endocytic pathway are inter-
connected, receiving a continuous flow of both newly syn-
thesized protein and lipid moieties as well as material
internalized from the plasma membrane (Kornfeld and
Mellman, 1989; Mellman, 1996). If the organelles described
here originate from each other through the process of mat-
uration, the different distributions of class II–associated Ii
fragments and HLA-DM might reflect encounter of pro-
teases that degrade Ii at a stage that precedes accumula-
tion of HLA-DM in a denser organelle. Alternatively, the
here described organelle populations represent distinct com-
partments, as suggested from the absence of HLA-DM from
the lighter, Ii positive endocytic organelles and the fact
that HRP (being protease resistant) was not found in the
HLA-DM–containing organelle.
Interestingly, targeting of Ii and HLA-DM from the
trans-Golgi network to class II–containing post-Golgi or-
Figure 8. Kinetics of transport of 125I-tetanus toxin C fragment through intracellular compartments in Mel JuSo cells transfected with
mIgG. Cells were allowed to internalize 125I-tetanus toxin C fragment for 5 min, followed by a chase for the times indicated in the differ-
ent panels. Membranes were prepared and fractionated by sucrose density centrifugation (a) and organelle electrophoresis (b and c) for
the times indicated.
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ganelles is mediated via distinct types of signals: Ii is tar-
geted via dileucine based signals that reside within the cy-
toplasmic tail (Bakke and Dobberstein, 1990; Lotteau et al.,
1990; Pieters et al., 1993) whereas HLA-DM contains a ty-
rosine-based motif in its cytoplasmic tail (Copier et al. 1996;
Lindstedt et al. 1995; Marks et al. 1995). Both dileucine and
tyrosine based signals appear to interact with adaptor pro-
teins associated with clathrin (Hunziker and Fumey, 1994;
Ohno et al., 1995). However, Marks et al. (1996) recently
showed that dileucine and tyrosine based targeting events
are mediated by distinct saturable components. While these
authors suggested that Ii and HLA-DM may travel via dif-
ferent routes to MHC class II compartments, our results
suggests that di-leucine and tyrosine based signals may spec-
ify different locations.
Transport of Peptide-loaded Class II Complexes to the 
Plasma Membrane
How are peptide loaded class II molecules transported to
the plasma membrane? The results presented here suggest
that more then one possibility exists. First, at the earliest
time points after biosynthesis that SDS stable ab com-
plexes could be detected (2 h), small amounts of stable
complexes comigrated with plasma membrane fractions. This
suggests a rapid and direct transport of peptide-loaded
class II complexes from the peptide-loading compartment
to the plasma membrane, possibly involving early endo-
somes (Tulp et al., 1994; Raposo et al., 1996; Pond and
Watts, 1997). Alternatively, peptide-loaded class II mole-
cules may follow retrograde transport from the peptide-
loading compartment through the Ii-containing endocytic
organelles to reach the plasma membrane.
An interesting possibility is that depending on the nature
of the peptides acquired in the loading compartment, class
II complexes may either directly be deposited at the
plasma membrane, or recycle between endocytic organelles
and the HLA-DM–containing loading compartment. Re-
cycling may continue until a productive peptide–class II
interaction has occurred that will result in stable cell sur-
face expression. The observed transit of class II complexes
through endocytic organelles even after prolonged times
of chase, is compatible with such a model. During such re-
cycling, peptides might also be exchanged on class II mole-
cules in endocytic organelles in an HLA-DM–independent
manner (Pinet et al., 1995; Warmerdam et al., 1996; Cella
et al., 1997).
Class II Compartments and the
Endosomal/Lysosomal Pathway
Remarkably, the peptide-loading compartment, in contrast
to the compartment where Ii is being degraded, was not di-
rectly accessible from the endocytic pathway. Whereas the
fluid phase endocytic tracer HRP did not access the pep-
tide-loading compartment, significant amounts of antigen
that were internalized via mIgG molecules, however, could
be detected in the HLA-DM positive loading compart-
ment. In the latter case, relatively low levels of radiola-
beled antigen were detected, which may be due either to
extensive proteolysis of the internalized antigen, or to the
fact that a large portion of the antigen cycles between the
plasma membrane and early endosomes before transport
to antigen degradation or peptide-loading compartments
(Watts and Davidson, 1988). Thus, antigen would not nec-
essarily accumulate in this compartment. However, consis-
tent with the efficient antigen presentation capacity of these
cells (Knight et al., 1997), our data do suggest that in con-
trast to fluid phase internalized material, antigen internal-
ized via mIgG could access the peptide-loading compart-
ment. At present, it is not known where precisely antigens
are being degraded. In fact, distinct mechanisms may be
involved in antigen capture, processing, and transport to
the peptide-loading compartment. In support of this,
Mitchell et al. (1995) recently characterized a mutation in
the transmembrane region of mIgM, that abolished anti-
gen presentations, despite a normal uptake and degrada-
tion of the antigen (Mitchell et al., 1995).
In principle, MHC class II molecules are able to bind any
peptide as well as large polypeptide fragments (Stern et al.,
1994; Busch et al., 1996). Thus, if invariant chain degrada-
tion, antigen proteolysis, and MHC class II loading all oc-
curred within the same compartment, it might be difficult
to load enough class II molecules with appropriate pep-
tides to ensure adequate expression on the cell surface (Ger-
main and Rinker, 1993; Lanzavecchia, 1996). Segregation
of the peptide loading event from the bulk endocytic path-
way may thus prevent unproductive MHC class II–(poly)
peptide complex formation and thereby contribute to the
efficiency and specificity of antigen presentation through
selective recruitment of peptide-receptive class II mole-
cules and HLA-DM within the same subcellular compart-
ment.
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